Table 2.
Characteristic | No. of cases | No. of events | Two-year survival rate (± SE) in % | p-value |
GOLPH2 expression | 0.162 | |||
low | 59 | 9 | 86.4 ± 4.5 | |
high | 45 | 12 | 73.3 ± 6.6 | |
pT-status | < 0.001 | |||
pT1 | 53 | 2 | 96.3 ± 2.6 | |
pT2/3/4 | 51 | 19 | 64.7 ± 6.7 | |
Fuhrman grade | 0.001 | |||
G 1 | 11 | 0 | - | |
G 2 | 73 | 12 | 84.9 ± 4.2 | |
G 3/4 | 19 | 9 | 52.6 ± 11.5 | |
pN-status | 0.001 | |||
pN0 | 50 | 10 | 80.0 ± 5.7 | |
pN1+ | 10 | 7 | 40.0 ± 15.5 | |
Metastasis | < 0.001 | |||
M0 | 83 | 8 | 90.4 ± 3.2 | |
M1 | 21 | 13 | 42.9 ± 10.8 |
Survival times of patients with renal cell cancer according to clinico-pathological characteristics and GOLPH2 protein expression.